HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James A Eastham Selected Research

Margins of Excision

1/2022Clinical utility of subclassifying positive surgical margins at radical prostatectomy.
1/2019In Organ-confined Prostate Cancer, Tumor Quantitation Not Found to Aid in Prediction of Biochemical Recurrence.
1/2015The association between nerve sparing and a positive surgical margin during radical prostatectomy.
10/2014Significance and management of positive surgical margins at the time of radical prostatectomy.
4/2014Do margins matter? The influence of positive surgical margins on prostate cancer-specific mortality.
2/2014Positive surgical margins after radical prostatectomy: a systematic review and contemporary update.
1/2014Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy.
10/2013Radical prostatectomy: positive surgical margins matter.
4/2013Prognostic impact of subclassification of radical prostatectomy positive margins by linear extent and Gleason grade.
9/2012Long-term outcomes after high-dose postprostatectomy salvage radiation treatment.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


James A Eastham Research Topics

Disease

168Prostatic Neoplasms (Prostate Cancer)
01/2022 - 03/2002
99Neoplasms (Cancer)
01/2022 - 04/2002
28Margins of Excision
01/2022 - 12/2003
20Neoplasm Metastasis (Metastasis)
01/2021 - 08/2002
13Lymphatic Metastasis
01/2019 - 11/2003
11Disease Progression
01/2022 - 10/2004
10Extranodal Extension
12/2014 - 12/2003
5Urinary Incontinence
01/2021 - 12/2004
3Leukemia
10/2020 - 12/2003
3Venous Thrombosis (Deep-Vein Thrombosis)
07/2012 - 12/2003
2Pathologic Constriction (Stenosis)
03/2022 - 06/2011
2Lower Urinary Tract Symptoms
10/2021 - 03/2005
2Hemorrhage
07/2020 - 08/2019
2Bone Diseases (Bone Disease)
01/2017 - 07/2012
2Urinary Bladder Neoplasms (Bladder Cancer)
06/2014 - 06/2010
2Erectile Dysfunction
04/2012 - 02/2010
2Renal Cell Carcinoma (Grawitz Tumor)
06/2010 - 07/2009
2Adenocarcinoma
10/2007 - 04/2002
1Overactive Urinary Bladder (Overactive Bladder)
03/2022
1Stress Urinary Incontinence
03/2022
1Genetic Risk Score
01/2022
1Acquired Immunodeficiency Syndrome (AIDS)
01/2022
1Osteoporotic Fractures
01/2020
1Postoperative Hemorrhage
08/2019
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2019
1Long Term Adverse Effects
10/2016
1Pelvic Organ Prolapse
04/2014
1Incisional Hernia
11/2013
1Fistula
08/2012
1Pulmonary Embolism
07/2012
1Metabolic Bone Diseases (Osteopenia)
07/2012
1Embolism (Embolus)
07/2012

Drug/Important Bio-Agent (IBA)

72Prostate-Specific Antigen (Semenogelase)IBA
01/2022 - 04/2002
23AndrogensIBA
01/2019 - 11/2003
7Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2005
5Indicators and Reagents (Reagents)IBA
01/2018 - 08/2002
4AntigensIBA
01/2021 - 09/2009
4Hormones (Hormone)IBA
05/2016 - 02/2004
4Docetaxel (Taxotere)FDA Link
05/2016 - 12/2003
3Testosterone (Sustanon)FDA Link
08/2021 - 06/2005
3Zoledronic Acid (Zometa)FDA Link
07/2012 - 01/2007
2Hemoglobins (Hemoglobin)IBA
07/2020 - 08/2019
2Goserelin (Zoladex)FDA Link
07/2015 - 01/2010
2EstramustineFDA Link
07/2015 - 12/2003
2Proteins (Proteins, Gene)FDA Link
11/2014 - 07/2007
2Kazal Pancreatic Trypsin InhibitorIBA
09/2014 - 06/2008
2Dihydrotachysterol (AT 10)IBA
08/2011 - 03/2008
2DNA (Deoxyribonucleic Acid)IBA
07/2010 - 02/2009
2Urokinase Plasminogen Activator ReceptorsIBA
01/2010 - 04/2007
2Tissue Kallikreins (Tissue Kallikrein)IBA
01/2010 - 02/2007
2Kallikreins (Kallikrein)IBA
04/2009 - 11/2007
2Anti-Bacterial Agents (Antibiotics)IBA
08/2006 - 04/2002
1GP 4 (GP4)IBA
01/2022
1Lactic Acid (Lactate)FDA LinkGeneric
01/2020
1Pyruvic Acid (Pyruvate)IBA
01/2020
1BAY 86-7548IBA
01/2019
1ParaffinIBA
01/2019
1Pharmaceutical PreparationsIBA
01/2017
1mCherry fluorescent proteinIBA
10/2016
16H,8H- 3,4- dihydropyrimido(4,5- c)(1,2)oxazin- 7- oneIBA
09/2016
1Carboplatin (JM8)FDA LinkGeneric
07/2015
1Paclitaxel (Taxol)FDA LinkGeneric
07/2015
1Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
11/2014
1Exopeptidases (Exopeptidase)IBA
11/2014
1AminopeptidasesIBA
11/2014
1antineoplaston A10 (A 10)IBA
04/2014
1Radium-223IBA
12/2013
1RadiopharmaceuticalsIBA
12/2013
1Abiraterone AcetateIBA
09/2012
1sipuleucel-T (APC8015)FDA Link
09/2012
1Diphosphonates (Bisphosphonates)IBA
07/2012
1Complement System Proteins (Complement)IBA
07/2012
1Collagen Type I (Type I Collagen)IBA
07/2012
1TESIBA
07/2012
1taxaneIBA
03/2012

Therapy/Procedure

158Prostatectomy (Retropubic Prostatectomy)
03/2022 - 03/2002
57Therapeutics
03/2022 - 11/2003
40Radiotherapy
01/2021 - 06/2003
14Lymph Node Excision (Lymph Node Dissection)
01/2021 - 08/2002
9Castration
01/2021 - 06/2005
7Aftercare (After-Treatment)
08/2021 - 05/2002
7Salvage Therapy
01/2021 - 11/2003
6Brachytherapy
01/2021 - 06/2005
6Drug Therapy (Chemotherapy)
01/2019 - 11/2003
5Adjuvant Radiotherapy
01/2019 - 10/2005
3Combined Modality Therapy
01/2017 - 11/2003
3Operative Surgical Procedures
10/2016 - 11/2005
3Cystectomy
06/2014 - 07/2009
2Neoadjuvant Therapy
05/2016 - 05/2015
2Treatment Delay
01/2013 - 04/2009
2Conservative Treatment
05/2011 - 06/2005
2Cryotherapy (Therapy, Cold)
10/2007 - 11/2005
1Blood Transfusion (Blood Transfusions)
08/2019
1Immunotherapy
01/2019
1General Anesthesia
12/2014
1Anesthesia
12/2014
1Pessaries
04/2014
1Urinary Diversion (Ileal Conduit)
08/2012
1Sutures (Suture)
02/2012
1Minimally Invasive Surgical Procedures
11/2011